Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · Real-Time Price · USD

2.670

0.00 (0.00%)

At close: Apr 28, 2026, 4:00 PM EDT

2.650

-0.020 (-0.75%)

After-hours: Apr 28, 2026, 7:30 PM EDT

Spero Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Spero Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Spero Therapeutics.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	2	2	2	1	1
Buy	1	1	1	1	1
Hold	0	0	0	1	2
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	3	3	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+87.27%	Jan 30, 2025
Josh Schimmer Evercore ISI Group	Evercore ISI Group	Buy → Hold Downgrades $5	Buy → Hold	Downgrades	$5	+87.27%	Dec 20, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+87.27%	Dec 2, 2024
Ritu Baral TD Cowen	TD Cowen	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 18, 2024
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

816.00K

from 66.80M

-98.78%

from 66.80M

Revenue Next Year

3.26M

from 816.00K

300.00%

from 816.00K

EPS This Year

0.68

from 0.15

355.60%

from 0.15

EPS Next Year

-0.69

from 0.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	18.26M	53.51M	103.78M	47.98M	66.80M	816.00K	3.26M
Revenue Growth	95.67%	193.10%	93.95%	-53.77%	39.24%	-98.78%	300.00%
EPS	-2.91	-1.23	0.43	-1.27	0.15	0.68	-0.69
EPS Growth	-	-	-	-	-	355.60%	-
Forward PE	-	-	-	-	-	3.91	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	840,000	3.4M
Avg	816,000	3.3M
Low	784,000	3.1M

Revenue Growth

Revenue Growth	2026	2027
High	-98.7%	311.8%
Avg	-98.8%	300.0%
Low	-98.8%	284.3%

EPS Forecast

EPS	2026	2027
High	0.70	-0.71
Avg	0.68	-0.69
Low	0.66	-0.67

EPS Growth

EPS Growth	2026	2027
High	369.0%	-
Avg	355.6%	-
Low	337.7%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.